Device therapy for heart failure

American Journal of Cardiology

Volumn 91, Issue 6 SUPPL. 1, 2003, Pages 53-59

  Boehmer, John P ^a,b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANAMNESIS; BLOOD PUMP; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DEATH; DEFIBRILLATOR; DEVICE; EXERCISE; HEART ARRHYTHMIA; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PACING; HEART RHYTHM; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; IMPLANTATION; MONITOR; MORBIDITY; MORTALITY; PACEMAKER; PATIENT MONITORING; PRIORITY JOURNAL; PROSTHESIS; REVIEW; SURVIVAL; TIME;

EID: 0037456942     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)03380-5     Document Type: Review

References (60)

1. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
2. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure US Carvedilol Heart Failure Study Group. N Engl J Med. 334:1996;1349-1355.
3. Packer M., Coats A.J., Fowler M.B., Katus H.A., Krum H., Mohacsi P., Rouleau J.L., Tendera M., Castaigne A., Roecker E.B., Schultz M.K., DeMets D.L. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 344:2001;1651-1658.
4. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet. 353:1999;2001-2007.
5. Pitt B., Sannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 341:1999;709-717.
6. Ziesche S., Cobb F.R., Cohn J.N., Johnson G., Tristani F. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure results from V-HeFT I and V-HeFT II. Circulation. 87:(suppl):1993;VI56-VI64.
7. Gullestad L., Manhenke C., Aarsland T., Skardal R., Fagertun H., Wikstrand J., Kjekshus J. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure a substudy to the MERIT-HF trial. Eur J Heart Fail. 3:2001;463-468.
8. Fowler M.B. Effects of beta blockers on symptoms and functional capacity in heart failure. Am J Cardiol. 80:1997;55L-58L.
9. Rose E.A., Gelijns A.C., Moskowitz A.J., Heitjan D.F., Stevenson L.W., Dembitsky W., Long J.W., Ascheim D.D., Tierney A.R., Levitan R.G. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 345:2001;1435-1443.
10. Willerson JT: Effect of carvedilol on mortality and morbidity in patients with chronic heart failure [news]. Circulation 1996;94:592.
11. Pitt B., Poole-Wilson P.A., Segal R., Martinez F.A., Dickstein K., Camm A.J., Konstam M.A., Riegger G., Klinger G.H., Neaton J., Sharma D., Thiyagarajan B. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure randomised trial - the Losartan Heart Failure Survival Study ELITE II. Lancet. 355:2000;1582-1587.
12. Garg R., Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure Collaborative Group on ACE Inhibitor Trials. JAMA. 273:1995;1450-1456.
13. Kjekshus J., Swedberg K., Snapinn S. Effects of enalapril on long-term mortality in severe congestive heart failure CONSENSUS Trial Group. Am J Cardiol. 69:1992;103-107.
14. Pfeffer M.A., Braunwald E., Moye L.A., Basta L., Brown E.J. Jr, Cuddy T.E., Davis B.R., Geltman E.M., Goldman S., Flaker G.C., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction results of the Survival and Ventricular Enlargement trial. N Engl J Med. 327:1992;669-677.
15. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
16. Roe C.M., Motheral B.R., Teitelbaum F., Rich M.W. Compliance with and dosing of angiotensin-converting enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm. 57:2000;139-145.
17. Roe C.M., Motheral B.R., Teitelbaum F., Rich M.W. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J. 138:1999;818-825.
18. Monane M., Bohn R.L., Gurwitz J.H., Glynn R.J., Avorn J. Noncompliance with congestive heart failure therapy in the elderly. Arch Intern Med. 154:1994;433-437.
19. Vinson, JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc 1990;38:1290-1295.
20. O'Connell J.B. The economic burden of heart failure. Clin Cardiol. 23:(suppl):2000;III6-III10.
21. Cleland JGF. Telemonitoring for heart failure. TENS-HMS: patient characteristics and final results. Paper presented at the European Society of Cardiology Congress; August 31-September 4, 2002; Berlin, Germany.
22. Ohlsson A., Bennett T., Ottenhoff F., Bitkover C., Kjellstrom B., Nordlander R., Astrom H., Ryden L. Long-term recording of cardiac output via an implantable haemodynamic monitoring device. Eur Heart J. 17:1996;1902-1910.
23. Braunschweig F., Linde C. Continuous hemodynamic monitoring in heart failure. J Cardiovasc Electrophysiol. 13:(suppl):2002;S68-S72.
24. Braunschweig F., Linde C., Eriksson M.J., Hofman-Bang C., Ryden L. Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J. 23:2002;59-69.
25. Ohlsson A., Kubo S.H., Steinhaus D., Connelly D.T., Adler S., Bitkover C., Nordlander R., Ryden L., Bennett T. Continuous ambulatory monitoring of absolute right ventricular pressure and mixed venous oxygen saturation in patients with heart failure using an implantable haemodynamic monitor results of a 1 year multicentre feasibility study. Eur Heart J. 22:2001;942-954.
26. Ohlsson A., Nordlander R., Bennett T., Bitkover C., Kjellstrom B., Lee B., Ryden L. Continuous ambulatory haemodynamic monitoring with an implantable system the feasibility of a new technique. Eur Heart J. 19:1998;174-184.
27. Podrid P.J., Fogel R.I., Tordjman-Fuchs T. Arrhythmia in patients with a cardiomyopathy and congestive heart failure. Hosenpud J.D., Greenberg B.H. Congestive Heart Failure. 1994;653-654 Springer-Verlag, New York.
28. Cohn J.N., Johnson G.R., Shabetai R., Loeb H., Tristani F., Rector T., Smith R., Fletcher R. Ejection fraction, peak exercise oxygen consumption, cardiothoracic ratio, ventricular arrhythmias, and plasma norepinephrine as determinants of prognosis in heart failure the V-HeFT VA Cooperative Studies Group. Circulation. 87:(suppl):1993;VI5-V16.
29. Teerlink J.R., Jalaluddin M.S., Anderson S., Kukin M.L., Eichhorn E.J., Francis G., Packer M., Massie B.M. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation. 101:2000;40-46.
30. Singh S.N., Fisher S.G., Carson P.E., Fletcher R.D. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy Department of Veterans Affairs CHF STAT Investigators. J Am Coll Cardiol. 32:1998;942-947.
31. Goldman S., Johnson G., Cohn J.N., Cintron G., Smith R., Francis G for the. Mechanism of death in heart failure the Vasodilator-Heart Failure Trials. Circulation. 87:(suppl):1993;VI24-VI31.
32. Myerburg R.J., Kessler K.M., Castellanos A. Sudden cardiac death structure, function, and time-dependence of risk. Circulation. 85:(suppl):1992;I2-I10.
33. Moss A.J., Hall W.J., Cannom D.S., Daubert J.P., Higgins S.L., Klein H., Levine J.H., Saksena S., Waldo A.L., Wilber D., Brown M.W., Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 335:1996;1933-1940.
34. Buxton A.E., Lee K.L., Fisher J.D., Josephson M.E., Prystowsky E.N., Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med. 341:1999;1882-1890.
35. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 346:2002;877-883.
36. Bardy G., Lee K., Mark D. The sudden cardiac death in heart failure trial pilot study. [abstract] Pacing Clin Electrophysiol. 20:1997;1148.
37. Kadish A., Quigg R., Schaechter A., Anderson K.P., Estes M., Levine J. Defibrillators in nonischemic cardiomyopathy treatment evaluation. Pacing Clin Electrophysiol. 23:2000;338-343.
38. Kusumoto F.M., Goldschlager N. Cardiac pacing in patients with dilated cardiomyopathy. J Interv Card Electrophysiol. 1:1997;103-110.
39. Pachon J.C., Pachon E.I., Albornoz R.N., Pachon J.C., Kormann D.S., Gimenes V.M., Medeiros P.T., Silva M.A., Sousa J.E., Paulista P.P., Souza L.C., Jatene A.D. Ventricular endocardial right bifocal stimulation in the treatment of severe dilated cardiomyopathy heart failure with wide QRS. Pacing Clin Electrophysiol. 24:2001;1369-1376.
40. Moreira L.F., Stolf N.A. Dynamic cardiomyoplasty as a therapeutic alternative current status. Heart Fail Rev. 6:2001;201-212.
41. Kass D.A., Baughman K.L., Pak P.H., Cho P.W., Levin H.R., Gardner T.J., Halperin H.R., Tsitlik J.E., Acker M.A. Reverse remodeling from cardiomyoplasty in human heart failure external constraint versus active assist. Circulation. 91:1995;2314-2318.
42. Batista R. Partial left ventriculectomy the Batista procedure. Eur J Cardiothorac Surg. 15:(suppl 1):1999;S12-S19. S39-S43.
43. McCarthy J.F., McCarthy P.M., Starling R.C., Smedira N.G., Scalia G.M., Wong J., Kasirajan V., Goormastic M., Young J.B. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg. 114:1997;755-765.
44. Schreuder J.J., Steendijk P., van der Veen F.H., Alfieri O., van der Nagel T., Lorusso R., van Dantzig J.M., Prenger K.B., Baan J., Wellens H.J., Batista R.J. Acute and short-term effects of partial left ventriculectomy in dilated cardiomyopathy assessment by pressure-volume loops. J Am Coll Cardiol. 36:2000;2104-2114.
45. Starling R.C., Buda T., Wong J., Goormastic M., Smedira N.G., Thomas J.D., Blackstone E.H., Young J.B. Results of partial left ventriculectomy for dilated cardiomyopathy hemodynamic, clinical and echocardiographic observations. J Am Coll Cardiol. 36:2000;2098-2103.
46. Saavedra W.F., Tunin R.S., Paolucci N., Mishima T., Suzuki G., Emala C.W., Chaudhry P.A., Anagnostopoulos P., Gupta R.C., Sabbah H.N., Kass D.A. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol. 39:2002;2069-2076.
47. McCarthy P.M., Takagaki M., Ochiai Y., Tabata T., Shiota T., Qin J.X., Thomas J.D., Mortier T.J., Schroeder R.F., Schweich C.J. Jr, Fukamachi K. Device-based change in left ventricular shape a new concept for the treatment of dilated cardiomyopathy. J Thorac Cardiovasc Surg. 122:2001;482-490.
48. Takagaki M., McCarthy P.M., Ochiai Y., Dessoffy R., Doi K., Vidlund R., Mortier T.J., Schweich C.J. Jr, Fukamachi K. Novel device to change left ventricular shape for heart failure treatment device design and implantation procedure. ASAIO J. 47:2001;244-248.
49. Zhou Q., Henein M., Coats A., Gibson D. Different effects of abnormal activation and myocardial disease on left ventricular ejection and filling times. Heart. 84:2000;272-276.
50. Kass D.A., Chen C.H., Curry C., Talbot M., Berger R., Fetics B., Nevo E. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay. Circulation. 99:1999;1567-1573.
51. Aurrichio A, Stellbrink C, Block M, Sack S, Vogt J, Bakker P, Klein H, Kramer A, Ding J, Salo R, et al, for the Pacing Therapies for Congestive Heart Failure Study Group and the Guidant Congestive Heart Failure Research Group. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. Circulation 1999;99:2993-3001.
52. Nelson G.S., Berger R.D., Fetics B.J., Talbot M., Spinelli J.C., Hare J.M., Kass D.A. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 102:2000;3053-3059.
53. Eichhorn E.J., Heesch C.M., Barnett J.H., Alvarez L.G., Fass S.M., Grayburn P.A., Hatfield B.A., Marcouz L.G., Malloy C.R. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol. 24:1994;1310-1320.
54. Eichhorn E.J., Bedetto J.B., Malloy C.R., Hatfield B.A., Deitchman D., Brown M., Willard J.E., Grayburn P.A. Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure improvements in hemodynamic, contractile, and diastolic performance with bucindolol. Circulation. 82:1990;473-483.
55. Abraham W.T., Fisher W.G., Smith A.L., Delurgio D.B., Leon A.R., Loh E., Kocovic D.Z., Packer M., Clavell A.L., Hayes D.L. Cardiac resynchronization in chronic heart failure. N Engl J Med. 346:2002;1845-1853.
56. Saxon LA. Chronic resynchronization therapy results in reverse remodeling in mild to moderate heart failure. Circulation 2001;104(suppl)II-619.
57. Jessup M. Mechanical cardiac-support devices dreams and devilish details. N Engl J Med. 345:2001;1490-1493.
58. Underwood A. A year later, the beat goes on. Newsweek 2002;139:78-79.
59. Mehta S.M., Weiss W.J., Snyder A.J., Prophet G.A., Pae W.E. Jr, Rosenberg G., Pierce W.S. Testing of a 50 cc stroke volume completely implantable artificial heart expanding chronic mechanical circulatory support to women, adolescents, and small stature men. ASAIO J. 46:2000;779-782.
60. Weiss W.J., Rosenberg G., Snyder A.J., Pierce W.S., Pae W.E., Kuroda H., Rawhouser M.A., Felder G., Reibson J.D., Cleary T.J., et al. Steady state hemodynamic and energetic characterization of the Penn State/3M Health Care Total Artificial Heart. ASAIO J. 45:1999;189-193.